← Leaderboards
Fabio C Re
Dana-Farber Cancer Institute
$7,327,370
Attributed
$7,327,370
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $743.9K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,327,370 · 8
By mechanism
R01$5,132,034 · 3
R21$2,195,336 · 5
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Brian S Schaffhausen$13,414,255
- Karen Sue Anderson$9,175,456
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineCellsPublishingMouse ModelGenerationsResponseInfectionPathogenCell TypeInterleukin-18MediatingImmune ResponseBacterial InfectionsResistanceVaccinationVaccinesLungBaseAdjuvantReceptorIn VivoInterleukin-1 BetaPathway InteractionsCell Death
Grant awards (23)
Role of non-myeloid cells' pyroptosis in melioidosis$491,790
R01 · FY2025 · AI · contact PI
Improving vaccination against type-2 T-independent antigens$191,454
R21 · FY2025 · AI · contact PI
Role of non-myeloid cells' pyroptosis in melioidosis$507,000
R01 · FY2024 · AI · contact PI
Improving vaccination against type-2 T-independent antigens$236,850
R21 · FY2024 · AI · contact PI
Role of non-myeloid cells' pyroptosis in melioidosis$507,000
R01 · FY2023 · AI · contact PI
Inflammatory cytokines and pyroptosis in Coronavirus infection$429,000
R21 · FY2020 · AI · contact PI
Role of neutrophils and elastase in melioidosis$387,158
R01 · FY2019 · AI · contact PI
Role of neutrophils and elastase in melioidosis$387,242
R01 · FY2018 · AI · contact PI
Regulation of intestinal microbiota by B1 B cells during lung infection$195,000
R21 · FY2018 · AI · contact PI
Role of neutrophils and elastase in melioidosis$387,322
R01 · FY2017 · AI · contact PI
Regulation of intestinal microbiota by B1 B cells during lung infection$234,000
R21 · FY2017 · AI · contact PI
Role of neutrophils and elastase in melioidosis$387,999
R01 · FY2016 · AI · contact PI
Role of neutrophils and elastase in melioidosis$402,055
R01 · FY2015 · AI · contact PI
Role of NLRP3-inflammasome in alum's adjuvanticity$344,149
R01 · FY2014 · AI · contact PI
Role of NLRP3-inflammasome in alum's adjuvanticity$323,500
R01 · FY2013 · AI · contact PI
Role of NLRP3-inflammasome in alum's adjuvanticity$344,149
R01 · FY2012 · AI · contact PI
Role of NLRP3-inflammasome in alum's adjuvanticity$329,670
R01 · FY2011 · AI · contact PI
Role of NLRP3-inflammasome in alum's adjuvanticity$333,000
R01 · FY2010 · AI · contact PI
The NLR-inflammasome as mediator of Alum's adjuvanticity$179,033
R21 · FY2008 · AI · contact PI
The NLR-inflammasome as mediator of Alum's adjuvanticity$219,000
R21 · FY2007 · AI · contact PI
Multimeric MD-2 as an LPS decoy$232,125
R21 · FY2004 · AI
Multimeric MD-2 as an LPS decoy$22,374
R21 · FY2004 · AI
Multimeric MD-2 as an LPS decoy$256,500
R21 · FY2003 · AI